Board of Directors

The Board of Directors, comprised of leading COPD experts, is GOLD’s main governing body. It encourages dissemination and adoption of the reports on COPD management through utilization of existing health care structures in individual countries and promotes international collaboration on COPD research.

 
Board of Directors
Disclosures

Alvar G. Agusti, MD, Chair

Respiratory Institute,
Hospital Clinic, IDIBAPS
Univ. Barcelona and Ciberes

Barcelona, Spain

Richard Beasley, MD

Medical Research Institute of NZ

Wellington, New Zealand

Bartolome R. Celli, MD

Harvard Medical School

Boston, Massachusetts, USA

Rongchang Chen, MD

Shenzhen Institute of Respiratory Disease
Shenzhen People's Hospital

Shenzhen, PRC

Gerard Criner, MD

Temple University School of Medicine

Philadelphia, Pennsylvania, USA

David Halpin, MD

University of Exeter Medical School
College of Medicine and Health
University of Exeter, Exeter

Devon, UK

M. Victorina López Varela, MD

Universidad de la República

Montevideo, Uruguay

Maria Montes de Oca, MD

Hospital Universitario de Caracas
Universidad Central de Venezuela
Centro Médico de Caracas

Caracas, Venezuela

Kevin Mortimer, MD

Liverpool School of Tropical Medicine

Liverpool, UK

Sundeep Salvi MD

Pulmocare Research and Education
(PURE) Foundation

Pune, India

Claus Vogelmeier, MD

University of Marburg

Marburg, Germany

GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

View Board and Committee Annual Disclosures